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Objective. Our aim in this paper was to investigate the possible genetic association between three Ser563Asn, Leu125Val and
Arg670GlypolymorphismsofthePECAM-1geneandperiodontitis.Methods. GenomicDNAwasisolatedfromwholebloodof105
periodontalpatient(52withchronicperiodontitisand53withaggressive periodontitis)and101healthy individuals.Samples were
genotypedandanalyzedforthethreesingle-nucleotidepolymorphisms(SNPs)ofPECAM-1usingpolymerasechainreactionwith
sequence-speciﬁc primers (PCR-SSPs). Results. A statistically signiﬁcant diﬀerence was found between the genotypic distribution
of the Ser563Asn polymorphism in patients with periodontitis compared to controls (P = 0.0 2 ) .B u tt h e r ew e r en os t a t i s t i c a l l y
signiﬁcant diﬀerence between the allele frequencies in the diﬀerent groups (P = 0.05). The other two polymorphisms did not
show a statistically signiﬁcant diﬀerence in their allele and genotype frequencies between the groups. There was no statistically
signiﬁcant diﬀerence found for any of the polymorphisms allele and genotype distribution in aggressive and chronic periodontitis
either. Conclusions. No signiﬁcant association was found between the polymorphism tested and the subgroups of periodontitis,
further research is still necessary to determine whether this polymorphism can be used as a genetic marker of periodontitis.
1.Introduction
Genetic associations have been claimed to be eﬀective in
predisposition of individuals to periodontitis and have been
investigated widely in recent years. Periodontal diseases are
a result of destructive inﬂammatory processes aﬀecting the
supporting structures of the teeth, causing resorption of
alveolar bone, and formation of periodontal pockets [1].
Not everyone is equally susceptible to periodontitis. The
risk for development and/or progression of periodontitis are
thought to be determined in part by the host’s genotype [2].
Recently, there has been increasing interest in identifying
allelic variants of genes that can be used in risk assessment
of periodontal diseases [3]. Platelet endothelial cell adhesion
molecule-1 (PECAM-1/CD31) is a 130-kD vascular cell
adhesionandsignalingmoleculeoftheimmunoglobulin(Ig)
superfamily that is expressed on the surface of circulating
platelets,monocytes,neutrophils,andselectedT-cellsubsets.
It is also a major constituent of the endothelial cell inter-
cellular junction and plays a role in neutrophil recruitment
at inﬂammatory sites. There is good evidence to suggest
that PECAM-1 is a key participant in the adhesion cascade
leading to extravasation of leukocytes during the inﬂamma-
tory process [4]. PECAM-1 is encoded by a 75 kb gene that
resides at the end of the long arm of chromosome 17 [5].
It is a relatively large gene (110kbp) containing 16 exons
encoding the 6 Ig-like extracellular domains (exons 3–8),
a transmembrane domain (exon 9), and a relatively long
cytoplasmic domain (exons 10–16) [6, 7]. Exons 1 and 2
encodethe5  untranslatedregionsandthesignalpeptide[8].
Several aminoacid polymorphisms have been identiﬁed
in PECAM-1. These are located in exon 3 codon 80 altering a
valine to a methionine (V80M), exon 3 at codon 125 altering
a leucine to a valine (L125V), in exon 8 at codon 563 altering2 ISRN Dentistry
Table 1: Allele and genotype frequencies of the PECAM-1 and Arg670Gly polymorphism in patients with periodontitis and controls.
PECAM-1 and Arg670Gly polymorphism Periodontitis n = 105 Controls n = 101 P value
Allele—n (%)
Arg 103 (49%) 99 (48.9%) 0.99
Gly 107 (50.9%) 103 (51%)
Genotype—n (%)
Gly/Gly 8 (7.6%) 4( 4 % )
0.18 Gly/Arg 91 (86.7%) 95 (93.9%)
Arg/Arg 6 (5.7%) 2( 2 % )
Values are the numbers (percentages) of patientsor controls positivefor each allele or genotype. TheP values were calculated by theχ2 test from 3 × 2o r2× 2
contingency tables for genotypes and alleles, respectively.
an serine to a asparagine (S563N), and in exon 12 at codon
670alteringanargininetoaglycine(R670G).Thelatterthree
polymorphisms are in a strong linkage disequilibrium [9].
These polymorphisms were investigated in the present
paper. They have been previously associated with diseases
such as ischemic heart diseases, coronary artery disease,
stenosis, myocardial infarction (MI), and arthrosclerosis in
a number of studies [9–14].
Since these diseases are similar to periodontitis, since
they all are inﬂammatory in nature, and no study has yet
been undertaken on the possible association between these
polymorphisms and periodontal disease, we evaluated the
contribution of them in susceptibility to periodontal dis-
eases.
2.MaterialandMethods
In this case, control studies a total of 206 nonsmoking
subjects were recruited. 105 patients with periodontitis (36
females and 17 males; range of age: 15–60 years) consisting
of53patientswithaggressiveperiodontitis(AgP),52patients
withchronicperiodontitis(CP),and101healthyindividuals.
Periodontitiswasdiagnosedbasedonofthreeclinicalparam-
eters, probing depth (PD), clinical attachment loss (CAL),
and bleeding on probing index (BPI) and radiographic ﬁnd-
ings.Noneofpatientshadahistoryofcurrentmanifestations
of systemic diseases. Patients with severe medical disorders
(diabetes mellitus, immunological disorders, hepatitis, HIV
infection,andcardiovascularinvolvement),useoforthodon-
tic appliances, needing pre-medication for dental treatment,
chronic usage of anti-inﬂammatory drugs, present acute
necrotizing ulcerative gingivitis, and pregnant or lactating
woman were excluded from the study.
The diagnostic criteria of CP were the following: (1) the
amount of periodontal destruction was consistent with the
presence of local factors such as plaque and calculus; (2)
at least two sites had probing depth −5mm and clinical
attachment loss −1mm in every quadrant; the number of
the teeth with alveolar bone absorption more than 2/3 root
length was less than eight. The clinical criteria of AgP were
eightormoreteeth,atleast3ofthosewereotherthancentral
incisors or ﬁrst molars, had a probing depth −5mm and
clinical attachment loss −3mm. Subjects, even at young ages
not reporting familial aggregation of the disease, were not
classiﬁed as aggressive periodontitis cases and not included
in the present paper. In addition, 101 healthy volunteers,
without any periodontal disease, systemic inﬂammatory
disease and surgical treatment in the last four weeks were
considered as control. The absence of periodontitis was
determined according to the following criteria: (1) a
minimum of 22 teeth in situ, (2) having no sites with
>3mm probing depth, and (3) the absence of clinical
attachment loss. None of the control subjects had a history
of periodontitis or tooth loss because of pathogenic tooth
mobility. Furthermore, there was no bleeding on probing
or radiographic evidence of bone loss in these subjects. All
subjects signed an informed consent form before enrolment
into the study. 10mL of venous blood was collected from
eachsubjectintotubescontaining50mMofEDTA.Genomic
DNA was isolated from anticoagulated peripheral blood
buﬀy coat using Miller’s salting out method [15]. Then
the genomic DNA was kept at −80◦C until genotyping.
The genotyping was performed using PCR-sequence-speciﬁc
primers (PCR-SSPs) method [16]. Internal control primers
were included to control for false negative reactions. The
control primers at a 0.2μM concentration (5 -GCC TTC
CCA ACC ATT CCC TT and 5 -TCA CGG ATT TCT
GTT GTG TTT C-3 ) was used to amplify a 796bp seg-
ment of HLA-DR4 gene. The PECAM-1 Ser563Asn poly-
morphism was identiﬁed by the sequence-speciﬁc for-
ward primers and in combination with the consensus
reverse primers 5 -CTCTCCCTCCTGTTCCTTGT-3  and 5 -
CGGTGGATGAGGTCCAGATT-3 , respectively. Sequence-
speciﬁc forward primers in combination with the con-
sensus reverse primers 5 TAGGTCACAATGACGATGTCA-
3  and 5 -GTGGGAAATTATCCACAGTCC-3 ,r e s p e c t i v e l y
were used to identify the PECAM-1 Arg670Gly polymor-
phism and the 5 -TGCTGTTCTATAAGGATGACA-3  for-
ward primer and the 5 -GACTCACCTTCCACCAACAC-3 
common reverse primer were used for investigation of the
Leu125Val polymorphism.
Ampliﬁcation was carried out using a DNA Technology
MTC400inatotalvolumeof15μMthatcontained100ngof
genomicDNA,1mMeachallele-speciﬁcprimerpair,200μM
dNTP, 10mM Tris-HCl (PH = 8.3), 50mM KCl, 1.5mM
MgCl2, and 0.5IU Taq DNA polymerase. The reaction was
carried out as follows; initial denaturation at 94◦C for 2min,
followed by 30 cycles of ampliﬁcation at 96◦Cf o r2 0 S
and annealing at 64◦C for 50S, with extention for 40S
at 72◦C, with a ﬁnal extention for 2min at 72◦C. TheISRN Dentistry 3
Table 2: Allele and genotype frequencies of the PECAM-1 and Arg670Gly polymorphisms in aggressive and chronic periodontitis.
PECAM-1 and Arg670Gly
Arg/Arg Gly/Arg Gly/Gly Arg Gly
Aggressive periodontitis (5.7%) (88.7%) (5.7%) (50%) (50%)
Chronic periodontitis (5.8%) (84.6%) (9.6%) (48%) (51.9%)
No statistical diﬀerences were observed at all comparisons (χ2 test, P>0.05).
Table 3: Allele and genotype frequencies of the PECAM-1 and Leu125Val polymorphism in patients with periodontitis and controls.
PECAM-1 and Arg670Gly polymorphism Periodontitis n = 105 Controls n = 101 P value
Allele—n (%)
Leu 83 (39.5%) 75 (37.1%) 0.61
Val 127 (60.4%) 127 (62.8%)
Genotype—n (%)
Leu/Leu 13 (12.4%) 12 (11.9%)
0.81 Leu/Val 57 (54.3%) 51 (50.5%)
Val/Val 35 (33.3%) 38 (37.6)
P Value <0.05 was considered statistically signiﬁcant.
ampliﬁed PCR products were analyzed by 2% agarose gel
electrophoresis followed by 0.5μg/mL ethidium bromide
staining and ultraviolet visualization. The agarose gels were
reported by an investigator unaware of the samples.
Statistics. Allelic and genotypic frequencies were obtained
by direct counting. Contingency tables were used with chi-
square tests to compare observed genotype frequencies with
those expected under Hardy-Weinberg equilibrium. Chi-
squareandFisher’sexacttestswereusedtotestfordiﬀerences
in genotype and allele distribution between the groups with
the help of SPSS version 13 software. The odds ratio (OR)
was calculated along with its 95% CI, and P Value < 0.05 was
considered statistically signiﬁcant.The study was approved
by the Ethics Committee of University. Written informed
consents were obtained before entering the study.
3. Results
We investigated the genetic variability of the PECAM-1 gene
in 101 healthy controls and 105 patients with a mean age of
33.34 ±9.8a n d2 9 .12 ±7.71, respectively.
The results for the Leu125Val and Arg670Gly Allele and
genotype frequencies in patients and controls showed no
statistically signiﬁcant diﬀerence (Tables 1 and 3).
The allele frequencies of the Ser563Asn polymorphism
showed no signiﬁcant diﬀerence between the patients and
controls (P = 0.05). There was a statistically signiﬁcant
diﬀerence in the genotype distribution of this polymor-
phism. The homozygous genotype combination of Ser/563
was 23.8% in controls, 13.3% in patients (P = 0.02) and the
homozygous/Asn563 was 4% in controls, 12.4% in patients
(P = 0.02) (Table 5).
In addition, as shown in Tables 2, 4,a n d6, there was
no statistically signiﬁcant diﬀerence found in allele and
genotype diﬀerences between diﬀerent forms of periodonti-
tis.
4. Discussion
Periodontitis is an inﬂammatory disorder characterized by
connective tissue and alveolar bone destruction. The correla-
tion of known polymorphisms in components of the human
immune system with phenotypes for certain patient groups
currently appears to provide the most promising application
of genetic determinants of periodontitis. In this paper we
investigated the three most popular SNPs of the PECAM-1
gene. The Ser563Asn polymorphism codes the extracellular
domain of the PECAM-1 molecule. We found no signiﬁcant
allele frequency distribution diﬀerence between the patients
and controls for this polymorphism (P = 0.05), but a
statisticallysigniﬁcantdiﬀerenceinthegenotypedistribution
of this polymorphism was found (P = 0.02). Therefore, we
cannot totally rule out the association of this polymorphism
with periodontitis, but certainly further investigations are
needed. Although such polymorphisms usually do not aﬀect
the gene expression, it results in an aminoacid change from
Ser to Asn in the functional Ig-like domain of PECAM-1,
but its role is not yet fully understood. It has been shown
that the nutrophil speciﬁc antigen (CD177) is involved in
transmigration of PMN via their attachment to this domain
[17].
Somestudieshavefoundrelationshipsbetweenthispoly-
morphism and diseases such as stenosis, myocardial infarc-
tion (MI), and arthrosclerosis [10, 11, 13, 14]. But to our
knowledge, there have been no similar studies on the asso-
ciation of this polymorphism and periodontitis to compare
our results with.
PECAM-1 creates its hemophilic bonds through its ﬁrst
or second Ig-like (d1/2) extracellular domain [18, 19], and
these hemophilic bonds have an important role in interen-
dothelial cell bindings [20] and transendothelial migration
of monocytes [21, 22].
Since the Leu125Val (C + 373G) polymorphism is in the
ﬁrst and second domain of PECAM-1 and the importance of4 ISRN Dentistry
Table 4: Allele and genotype frequencies of the PECAM-1 and Leu125Val polymorphisms in aggressive and chronic periodontitis.
PECAM-1 and Arg670Gly
Leu/Leu Leu/Val Val/Val Leu Val.
Aggressive periodontitis (11.3%) (52.8%) (35.8%) (37.7%) (62.2%)
Chronic periodontitis (13.5%) (55.8%) (30.8%) (30.7%) (58.6%)
No statistical diﬀerences were observed at all comparisons (χ2 test, P>0.05).
Table 5: Allele and genotype frequencies of the PECAM-1 and Ser563Asn polymorphism in patients with periodontitis and controls.
PECAM-1 and Ser563Asn polymorphism Periodontitis n = 105 Controls n = 101 P value
Allele—n (%)
Ser 106 (50.4%) 121 (60%) 0.05
Asn 104 (49.5%) 81 (40%)
Genotype—n (%)
Ser/Ser 14 (13.3%) 24 (23.8%)
0.02 Ser/Asn 78 (74.3%) 73 (72.3%)
Asn/Asn 13 (12.4%) 4( 4 % )
P Value <0.05 was considered statistically signiﬁcant.
Table 6: Allele and genotype frequencies of the PECAM-1 and Ser563Asn polymorphisms in aggressive and chronic periodontitis.
PECAM-1 and Arg670Gly
Ser/Ser Ser/Asn Asn/Asn Ser Asn
Aggressive periodontitis (13.2%) (73.6%) (13.2%) (50%) (50%)
Chronic periodontitis (13.5%) (75%) (11.5%) (50.9%) (49%)
No statistical diﬀerences were observed at all comparisons (χ2 test, P>0.05).
this domain and also previous ﬁndings showing the associ-
ation of this polymorphism with diseases such as coronary
artery disease, atherosclerosis, and ischemic heart diseases;
[9, 14] we decided to investigate its possible association with
periodontitis.
The results of our paper showed no statistically signif-
icant association between allele and genotype frequency in
periodontal patients and controls (P = 0.61 and P = 0.81).
We found no similar study to compare our results.
PECAM-1 appears to interact both with it (hemophilic
adhesion) and with non-PECAM-1 ligands (heterophilic
adhesion).
The cytoplasmic domin of this molecule has an impor-
tant role in regulating its cellular adhesion behavior and is
coded by exons 10–16 [18].
Although the exact role of the exon 12 cytoplasmic
domin is not clear yet, the Arg670Gly polymorphism in this
exonhasbeenfoundtoberelatedtodiseasessuchasischemic
heart diseases, MI and Stenosis [10, 12].
Considering the similar immunologic and inﬂammatory
basis of these diseases and periodontitis, we decided to eval-
uate the possible role of this polymorphism in periodontitis.
However, we found no statistically signiﬁcant association
between the diﬀerent genotype and allele frequency distribu-
tion of this polymorphism and periodontitis.
Taken together, this paper showed no statistically signiﬁ-
cant relation between these polymorphisms and periodonti-
tis, but further studies are still recommended.
5. Conclusion
No signiﬁcant association was found between the polymor-
phism tested and the subgroups of periodontitis, further
researchisstillnecessarytodeterminewhetherthispolymor-
phism can be used as a genetic marker of periodontitis.
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